by Ariana | Mar 27, 2025 | Article
Learn how the TULIP trials demonstrated that anifrolumab significantly improves rates of lupus low disease activity state (LLDAS) and remission in SLE patients. Anifrolumab is one of the only two biologic treatments approved for patients with moderate to severe SLE....
by Ariana | Mar 27, 2025 | Article
Arielle Mendel, MD, M.Sc., Junior Scientist, RI-MUHC, Montreal General Hospital site Assistant Professor, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University Department of Medicine, Division of Rheumatology, MUHC Study: REcombinant...
by Ariana | Mar 27, 2025 | Article
Advocating for Lupus Research in Canada Why Advocacy Matters for Canada’s Lupus Community Despite advances in lupus treatments, there are notable gaps that require attention and improvement in Canada. Learn More The Importance of Advocacy Driving Change for Lupus...
by Ariana | Feb 21, 2025 | Article
Quebec Association of Pharmacist Owners The pandemic and the aging of the population have highlighted the challenges facing the healthcare system but have also shed light on the role of community pharmacists. Essential to helping patients and reducing pressure on the...
by Ariana | Jan 15, 2025 | Article
NOTICE IS HEREBY GIVEN, that Lupus Canada will host its 2025 Annual General Meeting on Monday February 24th, 2025 at 8:30pm EST via Zoom. Lupus Canada is inviting you to a scheduled Zoom meeting. Topic: Lupus Canada AGMTime: Feb 24, 2025 08:30 PM Eastern Time (US and...
